Comparison of CT During Arterial Portography and MR During Arterial Portography in the Detection of Liver Metastases
W. P. Hosch1,
S. M. Schmidt1,
S. Plaza1,
C. Dechow1,
J. Schmidt2,
S. Ley3,
G. W. Kauffmann1 and
J. Hansmann1
1 Department of Radiology, University Clinic Heidelberg, INF 110, Heidelberg
69120, Germany.
2 Department of Surgery, University Clinic Heidelberg, Heidelberg,
Germany.
3 Department of Radiology, German Cancer Research Center (DKFZ), Heidelburg,
Germany.

View larger version (103K):
[in a new window]
|
Fig. 1 A Comparison between CT during arterial portography (A) and
MR during arterial portography (B) of lesion-to-liver contrast of two
metastases in right liver lobe (arrows) of 64-year-old man.
Improvement of lesion-to-liver contrast lowers rate of false-negative
findings.
|
|

View larger version (99K):
[in a new window]
|
Fig. 1 A Comparison between CT during arterial portography (A) and
MR during arterial portography (B) of lesion-to-liver contrast of two
metastases in right liver lobe (arrows) of 64-year-old man.
Improvement of lesion-to-liver contrast lowers rate of false-negative
findings.
|
|

View larger version (6K):
[in a new window]
|
Fig. 2 Evaluation of contrast homogeneity of liver parenchyma on CT during
arterial portography (gray bars) and MR during arterial portography
(black bars) after contrast medium administration (n = 45,
15 patients by three radiologists).
|
|

View larger version (9K):
[in a new window]
|
Fig. 3 Diagnostic confidence in evaluating hepatic liver lesions with CT
during arterial portography (n =234) (gray bars) and MR
during arterial portography (n = 252) (black bars).
|
|

View larger version (102K):
[in a new window]
|
Fig. 4A 64-year-old man with hemangioma of right liver lobe. CT images
before contrast medium application (A), during arterial portography
(B), and during delayed enhancement (C). Because of findings at
CT during arterial portography and during contrast enhancement, all observers
misinterpreted lesion as malignant.
|
|

View larger version (101K):
[in a new window]
|
Fig. 4B 64-year-old man with hemangioma of right liver lobe. CT images
before contrast medium application (A), during arterial portography
(B), and during delayed enhancement (C). Because of findings at
CT during arterial portography and during contrast enhancement, all observers
misinterpreted lesion as malignant.
|
|

View larger version (110K):
[in a new window]
|
Fig. 4C 64-year-old man with hemangioma of right liver lobe. CT images
before contrast medium application (A), during arterial portography
(B), and during delayed enhancement (C). Because of findings at
CT during arterial portography and during contrast enhancement, all observers
misinterpreted lesion as malignant.
|
|

View larger version (116K):
[in a new window]
|
Fig. 4D 64-year-old man with hemangioma of right liver lobe. Images from
T1-weighted fast low-angle shot (FLASH) (D), T2-weighted turbo
spin-echo (E), MR during arterial portography [MRAP] (F),
T1-weighted FLASH during delayed enhancement (G). Progressing
peripheral enhancement during dynamic contrast enhancement is more visible
during MRI because of application of full systemic dose of contrast medium
during MRAP. Using MRI, all observers correctly characterized this lesion as
benign because of hyperintensity in T2-weighted turbo spin-echo and peripheral
enhancement in delayed enhancement.
|
|

View larger version (119K):
[in a new window]
|
Fig. 4E 64-year-old man with hemangioma of right liver lobe. Images from
T1-weighted fast low-angle shot (FLASH) (D), T2-weighted turbo
spin-echo (E), MR during arterial portography [MRAP] (F),
T1-weighted FLASH during delayed enhancement (G). Progressing
peripheral enhancement during dynamic contrast enhancement is more visible
during MRI because of application of full systemic dose of contrast medium
during MRAP. Using MRI, all observers correctly characterized this lesion as
benign because of hyperintensity in T2-weighted turbo spin-echo and peripheral
enhancement in delayed enhancement.
|
|

View larger version (96K):
[in a new window]
|
Fig. 4F 64-year-old man with hemangioma of right liver lobe. Images from
T1-weighted fast low-angle shot (FLASH) (D), T2-weighted turbo
spin-echo (E), MR during arterial portography [MRAP] (F),
T1-weighted FLASH during delayed enhancement (G). Progressing
peripheral enhancement during dynamic contrast enhancement is more visible
during MRI because of application of full systemic dose of contrast medium
during MRAP. Using MRI, all observers correctly characterized this lesion as
benign because of hyperintensity in T2-weighted turbo spin-echo and peripheral
enhancement in delayed enhancement.
|
|

View larger version (111K):
[in a new window]
|
Fig. 4G 64-year-old man with hemangioma of right liver lobe. Images from
T1-weighted fast low-angle shot (FLASH) (D), T2-weighted turbo
spin-echo (E), MR during arterial portography [MRAP] (F),
T1-weighted FLASH during delayed enhancement (G). Progressing
peripheral enhancement during dynamic contrast enhancement is more visible
during MRI because of application of full systemic dose of contrast medium
during MRAP. Using MRI, all observers correctly characterized this lesion as
benign because of hyperintensity in T2-weighted turbo spin-echo and peripheral
enhancement in delayed enhancement.
|
|

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Copyright © 2006 by the American Roentgen Ray Society.